Literature DB >> 28448691

Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1.

Young B Hong1, Jin-Mo Park2, Jin S Yu3, Da H Yoo3, Da E Nam3, Hyung J Park4, Ji-Su Lee5, Sun H Hwang5, Ki W Chung3, Byung-Ok Choi5,6.   

Abstract

Mutations in the gap junction protein beta 1 gene (GJB1) cause X-linked Charcot-Marie-Tooth disease type 1 (CMTX1). CMTX1 is representative of the intermediate type of CMT, having both demyelinating and axonal neuropathic features. We analyzed the clinical and genetic characterization of 128 patients with CMTX1 from 63 unrelated families. Genetic analysis revealed a total of 43 mutations including 6 novel mutations. Ten mutations were found from two or more unrelated families. p.V95M was most frequently observed. The frequency of CMTX1 was 9.6% of total Korean CMT family and was 14.8% when calculated within genetically identified cases. Among 67 male and 61 female patients, 22 females were asymptomatic. A high-arched foot, ataxia, and tremor were observed in 87%, 41%, and 35% of the patients, respectively. In the male patients, functional disability scale, CMT neuropathy score, and compound muscle action potential of the median/ulnar nerves were more severely affected than in the female patients. This study provides a comprehensive summary of the clinical features and spectrum of GJB1 gene mutations in Korean CMTX1 patients.
© 2017 Peripheral Nerve Society.

Entities:  

Keywords:  CMTX1; Charcot-Marie-Tooth disease (CMT); Korean; gap junction protein beta 1 (GJB1)

Mesh:

Substances:

Year:  2017        PMID: 28448691     DOI: 10.1111/jns.12217

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  2 in total

1.  An 8-generation family with X-linked Charcot-Marie-Tooth: Confirmation Of the pathogenicity Of a 3' untranslated region mutation in GJB1 and its clinical features.

Authors:  Dong-Hui Chen; Maxwell Ma; Mena Scavina; Elizabeth Blue; John Wolff; Prasanthi Karna; Michael O Dorschner; Wendy H Raskind; Thomas D Bird
Journal:  Muscle Nerve       Date:  2017-12-28       Impact factor: 3.217

Review 2.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.